MemTrax
MemTrax is a privately held health technology company offering a proprietary picture-based online memory test for early detection and tracking of Mild Cognitive Impairment, dementia, and Alzheimer's disease. It serves individual consumers via a freemium subscription model and is distributed through endorsements from Stanford, Yale Medicine, and the Alzheimer's Foundation of America.
- Company typePrivate
- Founded2015
- HeadquartersRedwood City, United States
- Headcount1–10
- GTM typeB2C
- OfferingSoftware
What MemTrax does
MemTrax is a Redwood City, California-based health technology company (MemTrax LLC) that operates an online cognitive assessment platform centered on a proprietary picture-based continuous recognition memory test. The test, which takes approximately three minutes to complete, measures learning and short-term memory performance and produces a Brain Health Score intended for early detection and longitudinal tracking of Mild Cognitive Impairment, dementia, and Alzheimer's disease. The underlying methodology was developed by founder Dr. J. Wesson Ashford starting in 1985, has Stanford IRB-approved research validation, and is supplemented by machine learning-based classification of MCI published in the Journal of Alzheimer's Disease (2020). A secondary Finger Tapping Test module extends the suite into motor-cognitive assessment.
MemTrax serves primarily individual consumers concerned about memory loss and cognitive aging through a freemium, direct-to-consumer model on memtrax.com, with secondary reach into healthcare providers and researchers via institutional endorsements (Stanford, Yale Medicine, Alzheimer's Foundation of America) and into corporate wellness programs. The platform is available globally in 120+ languages, 24/7, and emphasizes anonymity, no-credit-card trials, and visualized longitudinal results. Distribution is anchored on the company's own website and on the Alzheimer's Foundation of America's website as their featured memory test, providing institutional credibility without an enterprise sales motion.
The company is privately held, appears to be bootstrapped with no disclosed external funding, and operates with 1-10 employees. Its brand is trademarked (MemTrax™), its marketing is content-driven (brain health blog, SEO, social media), and its revenue mechanics are subscription-based premium plans layered over a free basic test. No mobile app, public API, certifications, regulatory clearances (e.g., FDA), or institutional investors are disclosed.
MemTrax firmographics
Firmographics- Name
- MemTrax
- Legal name
- MemTrax llc
- Website
- https://memtrax.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MemTrax is a privately held health technology company offering a proprietary picture-based online memory test for early detection and tracking of Mild Cognitive Impairment, dementia, and Alzheimer's disease. It serves individual consumers via a freemium subscription model and is distributed through endorsements from Stanford, Yale Medicine, and the Alzheimer's Foundation of America.
- Ownership category
- akta.pro rank
MemTrax industry classification
Industry- Product category
- Digital Cognitive Health Assessment
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Testing Laboratories (8734)
- akta.pro primary industry
- Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)
- akta.pro secondary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
Keywords
Where MemTrax is headquartered
LocationHeadquarters
- HQ city
- Redwood City
- HQ country
- United States
- HQ region
- North America
Markets served
MemTrax business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Subscription Plans: MemTrax offers tiered subscription plans for ongoing memory testing and tracking. The website mentions 'Plans' and 'Pricing' pages, indicating a subscription-based model with risk-free trials and no credit card required for initial signup.
- Freemium Test Access: Basic memory test available for free with premium features (unlimited tests, detailed tracking, history) available through paid subscription.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free Basic Test |
| Subscription | Monthly | Premium Subscription Plans |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
MemTrax product offering
Product offeringCore offering
MemTrax provides a web-based, picture-based continuous recognition memory test that screens learning and short-term memory performance in approximately 3 minutes, returning a Brain Health Score to help users track cognitive change over time. The platform is offered on a freemium basis, with paid subscription plans unlocking unlimited tests, full history, and detailed analytics, and is paired with a Finger Tapping Test for motor assessment. Target use cases include early detection of Mild Cognitive Impairment, dementia, and Alzheimer's disease for self-monitoring individuals and supporting research and clinical screening.
Product overview
MemTrax is a health technology company offering a suite of cognitive assessment tools centered around its core Online Memory Test. The primary offering is the MemTrax Memory Test, a picture-based cognitive screening tool that measures short-term memory function and provides a Brain Health Score to detect early signs of memory impairment, MCI, dementia, and Alzheimer's disease. The product suite includes a Finger Tapping Test (Tap Test) as an additional assessment module. The MemTrax test was developed by Dr. Wes Ashford and has been validated through Stanford IRB research and used in partnership with organizations like the Alzheimer's Foundation of America. The test is available online 24/7, supports over 120 language translations, and takes approximately 3 minutes to complete.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Test completion in approximately 3 minutes
- +2 more outcomes
Companies that use MemTrax
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
MemTrax technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
MemTrax partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Alzheimer's Foundation of AmericacoreThe Alzheimer's Foundation of America features MemTrax as their official memory test resource on their website, recognizing its precision and power for cognitive screening. This partnership provides significant credibility and distribution through a major nonprofit organization focused on dementia care.
- Stanford University ResearchcoreStanford IRB-approved research study validating the MemTrax memory test methodology. The test was developed by Dr. J. Wesson Ashford, a Stanford-trained psychiatrist with decades of research in cognitive assessment.
- Yale MedicineminorDr. Amos Adare, Neurosurgeon at Yale Medicine, endorses MemTrax, providing credibility within the medical research community.
- Journal of Alzheimer's DiseasecorePublished peer-reviewed research including 'Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment' (2020) validating the technology.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
MemTrax competitors and assessment
Company assessmentEmerging players
- Altoida: Altoida uses AI and augmented reality on smartphones to assess cognitive function and predict Alzheimer's risk. It overlaps with MemTrax on AI-driven cognitive assessment but differentiates through AR-based digital biomarkers and FDA Breakthrough Device designation.
- Savonix: Savonix offers a mobile cognitive assessment platform providing digital neurocognitive testing across domains including memory. It is a niche competitor in digital cognitive testing with partial overlap with MemTrax's short-term memory assessment focus.
- Neurotrack: Neurotrack develops digital cognitive health tools focused on memory assessment and dementia risk screening, including a 5-minute online test. It overlaps with MemTrax on the consumer-facing memory test concept, with partial overlap on AI-based screening.
Direct peers
- Cambridge Cognition: Cambridge Cognition offers digital cognitive assessment solutions for clinical trials, research, and healthcare providers, including tests for memory, attention, and executive function. It is one of the closest direct competitors to MemTrax in computerized memory testing with validated clinical positioning.
- Creyos (formerly Cambridge Brain Sciences): Creyos provides online cognitive assessments measuring memory, reasoning, and attention for both consumer health and clinical/research use. It competes directly with MemTrax in the digital cognitive assessment market with a broader product suite and stronger commercial traction.
- Cogstate: Cogstate provides computerized cognitive assessment tools used in clinical trials, research, and healthcare — directly comparable to MemTrax in offering brief, validated cognitive tests with a similar end-market focus on memory and cognition, but at much greater scale and with FDA-cleared products.
- CNS Vital Signs: CNS Vital Signs provides computerized neurocognitive testing platforms for clinicians and researchers, including memory domain assessments. It is a direct comparable in computerized cognitive testing with established healthcare-provider distribution.
- BrainCheck: BrainCheck offers a digital cognitive assessment platform used by clinicians to detect and manage cognitive impairment, concussion, and dementia. It is a direct competitor in the cognitive screening space with a focus on healthcare-provider customers, similar to MemTrax's secondary healthcare segment.
- Cognivue: Cognivue is an FDA-cleared digital cognitive screening device used in primary care to detect early signs of cognitive impairment. It competes with MemTrax in the cognitive assessment category but with a regulated medical-device positioning and clinical workflow focus.
Broad incumbents
- Lumos Labs (Lumosity): Lumosity operates a large-scale consumer brain-training platform with cognitive assessments across multiple domains including memory. While its primary positioning is brain training rather than clinical screening, it competes with MemTrax for consumer attention in the cognitive health space.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
MemTrax social profiles
Digital presenceMemTrax financial estimates
Financial estimateRevenue estimate
Valuation estimate
MemTrax leadership team
Management profileNumber of profiles
Profiles1 record
MemTrax funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MemTrax M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MemTrax
What does MemTrax do?
MemTrax provides a web-based, picture-based continuous recognition memory test that screens learning and short-term memory performance in approximately 3 minutes, returning a Brain Health Score to help users track cognitive change over time. The platform is offered on a freemium basis, with paid subscription plans unlocking unlimited tests, full history, and detailed analytics, and is paired with a Finger Tapping Test for motor assessment. Target use cases include early detection of Mild Cognitive Impairment, dementia, and Alzheimer's disease for self-monitoring individuals and supporting research and clinical screening.
Is MemTrax a public or private company?
MemTrax is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MemTrax founded?
MemTrax was founded in 2015. It employs 1 to 10 people.
Where is MemTrax based?
MemTrax is headquartered in Redwood City, United States, in the North America region.
How does MemTrax make money?
Two revenue lines are on record. Subscription Plans are the primary driver. The others are freemium Test Access.
Who are MemTrax's main competitors?
Emerging players on record are Altoida, Savonix and Neurotrack. Direct peers are Cambridge Cognition, Creyos (formerly Cambridge Brain Sciences), Cogstate, CNS Vital Signs, BrainCheck and Cognivue. Lumos Labs (Lumosity) is listed as a broad incumbent.
Does MemTrax have an API?
No public API is recorded for MemTrax.
What industry is MemTrax in?
MemTrax's product category is Digital Cognitive Health Assessment. Its primary akta.pro industry code is HLALABAK, Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms, with a secondary code of HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables). Its NAICS code is 621511 and its SIC code is 8734.